Anthony DeBoer, Synaffix VP of business development
Synaffix expands ADC deal from 2022 with MacroGenics
The Dutch biotech Synaffix, which has been active in the deal space out of the gate in 2023, is building on a deal it made …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
